Evaluation of the ALIBIRD mHealth Platform for Care of Patients With Lung Cancer: Prospective Pilot Study

Jose M Iniesta-Chamorro   ^{1, 2 *} , MSc ;   Maria Sereno   ^{3, 4 *} , MD, PhD ;   Beatriz Garrido-Rubiales   ^{3, 4} , BPharm ;   Marta Villarino Sanz   ^{3, 4} , PhD ;   Isabel Espinosa-Salinas   ⁵ , PhD ;   Sandra Falagán Martínez   ⁴ , MD ;   Gustavo Rubio Romero   ⁴ , MD ;   Juan Moreno-Rubio   ^{3, 4} , PhD ;   Beatriz Tabarés   ⁴ , MD, PhD ;   Yolanda Martín   ⁴ , BSc ;   Irene Hernández de Córdoba   ⁴ , MD ;   Maria Morales Parga   ⁴ , MD ;   Natalia Molinero   ⁶ , PhD ;   M Victoria Moreno-Arribas   ⁶ , PhD ;   Guillermo Reglero Rada   ^{6, 7} , PhD ;   Ana Ramírez de Molina   ^{5, 7} , PhD ;   Enrique J Gómez   ^{1, 2, 8} , PhD ;   Enrique Casado   ^{3, 4} , MD, PhD

¹ Biomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain

² Instituto de Investigación Hospital 12 de Octubre (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain

³ Clinical Oncology Group, IMDEA Nutrition, CEI UAM + CSIC, Madrid, Spain

⁴ Medical Oncology Department, Infanta Sofía University Hospital, Infanta Sofía and Henares Hospitals Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), Madrid, Spain

⁵ GENYAL Platform, IMDEA Nutrition, CEI UAM + CSIC, Madrid, Spain

⁶ Institute of Food Science Research (CIAL), Consejo Superior de Investigaciones Científicas (CSIC)–Universidad Autónoma de Madrid (UAM), Madrid, Spain

⁷ Molecular Oncology Group, IMDEA Nutrition, CEI UAM + CSIC, Madrid, Spain

⁸ Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain

*these authors contributed equally